78 related articles for article (PubMed ID: 19306365)
21. The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis.
Tarlinton RE; Khaibullin T; Granatov E; Martynova E; Rizvanov A; Khaiboullina S
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646507
[TBL] [Abstract][Full Text] [Related]
22. Hypothermia in Multiple Sclerosis: Beyond the Hypothalamus? A Case Report and Review of the Literature.
Berti F; Arif Z; Constantinescu C; Gran B
Case Rep Neurol Med; 2018; 2018():2768493. PubMed ID: 29755800
[TBL] [Abstract][Full Text] [Related]
23. Causes, effects and connectivity changes in MS-related cognitive decline.
Rimkus CM; Steenwijk MD; Barkhof F
Dement Neuropsychol; 2016; 10(1):2-11. PubMed ID: 29213424
[TBL] [Abstract][Full Text] [Related]
24. Amyloid-β Homeostasis Bridges Inflammation, Synaptic Plasticity Deficits and Cognitive Dysfunction in Multiple Sclerosis.
Stampanoni Bassi M; Garofalo S; Marfia GA; Gilio L; Simonelli I; Finardi A; Furlan R; Sancesario GM; Di Giandomenico J; Storto M; Mori F; Centonze D; Iezzi E
Front Mol Neurosci; 2017; 10():390. PubMed ID: 29209169
[TBL] [Abstract][Full Text] [Related]
25. MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.
Kaunzner UW; Gauthier SA
Ther Adv Neurol Disord; 2017 Jun; 10(6):247-261. PubMed ID: 28607577
[TBL] [Abstract][Full Text] [Related]
26. Imaging as an Outcome Measure in Multiple Sclerosis.
Ontaneda D; Fox RJ
Neurotherapeutics; 2017 Jan; 14(1):24-34. PubMed ID: 27699722
[TBL] [Abstract][Full Text] [Related]
27. Central Autonomic Dysfunction Delays Recovery of Fingolimod Induced Heart Rate Slowing.
Hilz MJ; Intravooth T; Moeller S; Wang R; Lee DH; Koehn J; Linker RA
PLoS One; 2015; 10(7):e0132139. PubMed ID: 26147106
[TBL] [Abstract][Full Text] [Related]
28. Perfusion and Diffusion Abnormalities of Multiple Sclerosis Lesions and Relevance of Classified Lesions to Disease Status.
Li L; Chopp M; Nejad-Davarani SP; Jafari-Khouzani K; Patel SC; Budaj J; Lu M; Elias SB; Cerghet M; Jiang Q
J Neurol Neurophysiol; 2014 Apr; 2014(Suppl 12):12. PubMed ID: 25642354
[TBL] [Abstract][Full Text] [Related]
29. Molecular magnetic resonance imaging of brain-immune interactions.
Gauberti M; Montagne A; Quenault A; Vivien D
Front Cell Neurosci; 2014; 8():389. PubMed ID: 25505871
[TBL] [Abstract][Full Text] [Related]
30. Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment.
Eloyan A; Shou H; Shinohara RT; Sweeney EM; Nebel MB; Cuzzocreo JL; Calabresi PA; Reich DS; Lindquist MA; Crainiceanu CM
PLoS One; 2014; 9(9):e107263. PubMed ID: 25233361
[TBL] [Abstract][Full Text] [Related]
31. Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010.
Cook SD; Dhib-Jalbut S; Dowling P; Durelli L; Ford C; Giovannoni G; Halper J; Harris C; Herbert J; Li D; Lincoln JA; Lisak R; Lublin FD; Lucchinetti CF; Moore W; Naismith RT; Oehninger C; Simon J; Sormani MP
Int J MS Care; 2012; 14(3):105-14. PubMed ID: 24453741
[TBL] [Abstract][Full Text] [Related]
32. A comprehensive approach to the segmentation of multichannel three-dimensional MR brain images in multiple sclerosis.
Datta S; Narayana PA
Neuroimage Clin; 2013; 2():184-96. PubMed ID: 24179773
[TBL] [Abstract][Full Text] [Related]
33. The Network Modification (NeMo) Tool: elucidating the effect of white matter integrity changes on cortical and subcortical structural connectivity.
Kuceyeski A; Maruta J; Relkin N; Raj A
Brain Connect; 2013; 3(5):451-63. PubMed ID: 23855491
[TBL] [Abstract][Full Text] [Related]
34. Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis.
Narayana PA; Zhou Y; Hasan KM; Datta S; Sun X; Wolinsky JS
Mult Scler; 2014 Mar; 20(3):365-73. PubMed ID: 23836878
[TBL] [Abstract][Full Text] [Related]
35. Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
Vrenken H; Jenkinson M; Horsfield MA; Battaglini M; van Schijndel RA; Rostrup E; Geurts JJ; Fisher E; Zijdenbos A; Ashburner J; Miller DH; Filippi M; Fazekas F; Rovaris M; Rovira A; Barkhof F; de Stefano N;
J Neurol; 2013 Oct; 260(10):2458-71. PubMed ID: 23263472
[TBL] [Abstract][Full Text] [Related]
36. Relevance of brain lesion location to cognition in relapsing multiple sclerosis.
Rossi F; Giorgio A; Battaglini M; Stromillo ML; Portaccio E; Goretti B; Federico A; Hakiki B; Amato MP; De Stefano N
PLoS One; 2012; 7(11):e44826. PubMed ID: 23144775
[TBL] [Abstract][Full Text] [Related]
37. Multi-modal quantitative MRI investigation of brain tissue neurodegeneration in multiple sclerosis.
Hasan KM; Walimuni IS; Abid H; Wolinsky JS; Narayana PA
J Magn Reson Imaging; 2012 Jun; 35(6):1300-11. PubMed ID: 22241681
[TBL] [Abstract][Full Text] [Related]
38. Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS.
Hasan KM; Walimuni IS; Abid H; Datta S; Wolinsky JS; Narayana PA
J Neurol Sci; 2012 Feb; 313(1-2):99-109. PubMed ID: 21978603
[TBL] [Abstract][Full Text] [Related]
39. Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI.
Kitzler HH; Su J; Zeineh M; Harper-Little C; Leung A; Kremenchutzky M; Deoni SC; Rutt BK
Neuroimage; 2012 Feb; 59(3):2670-7. PubMed ID: 21920444
[TBL] [Abstract][Full Text] [Related]
40. The generation and validation of white matter connectivity importance maps.
Kuceyeski A; Maruta J; Niogi SN; Ghajar J; Raj A
Neuroimage; 2011 Sep; 58(1):109-21. PubMed ID: 21722739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
